Tuesday, September 22, 2020

Myomo, Inc. (MYO) Soars After It Gets Certified as Medicare Provider

Must read

Seaport Global Securities Upgrade Vistra Corp. [VST]. What else is Wall St. saying?

Vistra Corp. loss -2.38% on the last trading session, reaching $18.42 price per share at the time. The company report on September 14,...

Xperi Holding Corporation [XPER] moved up 6.33: Why It’s Important

Xperi Holding Corporation traded at a high on 09/16/20, posting a 6.33 gain after which it closed the day’ session at $12.43. The...

Altimmune Inc. [ALT] Is Currently 11.16 above its 200 Period Moving Avg: What Dose This Mean?

Altimmune Inc. closed the trading session at $13.84 on 09/16/20. The day’s price range saw the stock hit a low of $12.48, while...

Market Analysts see Relay Therapeutics Inc. [RLAY] gaining to $36. Time to buy?

Relay Therapeutics Inc. jumped around 4.02 points on Friday, while shares priced at $44.20 at the close of the session, up 10.00%. Compared...

Shares of medical robotics firm surged 61% in premarket today with high volume as Myomo attains certification as Medicare Provider.  

Myomo, Inc. (MYO) shares are trading in bullish momentum followed the announcement of attaining the authorization of being a Medicare Provider. MYSO shares surged 61% in the premarket today and kicked off today’s trading session at $5.11. 

On Tuesday, MYO shares rose by almost 65% in the extended trading session. Myomo shares crossed the $5 mark for the first time since early March as later on, it followed the bearish market trend affected by COVID-19 pandemic.

The wearable medical robotics company recently reported that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company to be a Medicare Provider. The latest development has attracted investors and their interest in the stake of firm has increased.  

The company will now be able to bill Medicare directly when it delivers its MyoPro powered orthosis in 39 states and the District of Columbia. 

With the following authorization as a Medicare Provider, the company is now part of the Medicare Supplier Directory at Medicare.gov. Myomo highlighted that it is working to complete the requirements for billing Medicare for delivery in the remaining 11 states. 

MyoPro is based on upper-limb orthosis that is developed to support the arm and restore function to paralyzed or weak arms among the patients suffering from spinal cord injury, CVA stroke, ALS or other neuromuscular diseases, traumatic brain, and brachial plexus injury.

The Chief Commercial Officer of the company, Micah Mitchell stated:

“This certification is very important to Myomo. Not only does it allow us to bill Medicare directly in the future, it also opens the door to applying for in-network contracted coverage from many private commercial insurance companies as well as state Medicaid plans.”

The main goal of Myomo is to provide support to appropriate candidates with arm disabilities to obtain this useful technology for use at home, at work, and in school. 

This certification means that the company moves one step closer to attain commercial insurance plans. By commercializing MyoPro, the company will have coverage over a broader market which would help Myomo to potentially better serve the qualifying beneficiaries of Medicare and other plans who suffer a paralyzed or weakened arm caused by stroke or nerve injury. 

Myomo has not yet obtained reimbursement terms from CMS, and there is no guarantee at the moment that those terms will be implemented soon. However, provider status is a major push for the company to work on its product and requirements that are needed to obtain terms from CMS. 

As of 02:01 P.M. EDT, Myomo, Inc. (MYO) was trading $5.01 with soaring by almost 30%. MYO started the day peaking at $5.61 at $10:48 A.M EDT.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Lipocine Inc. [LPCN] Is Currently 5.92 above its 200 Period Moving Avg: What Dose This Mean?

Lipocine Inc. surged by $0.09 during the normal trading session on Friday and reaching a high of $1.62 during the day while it...

BJ’s Wholesale Club Holdings Inc. [BJ] moved up 2.97: Why It’s Important

BJ's Wholesale Club Holdings Inc. traded at a high on 09/18/20, posting a 2.97 gain after which it closed the day’ session at...

why Zuora Inc. [ZUO] is a Good Choice for Investors After New Price Target of $13.58

Zuora Inc. price surged by 2.98 percent to reach at $0.28. The company report on September 11, 2020 that Zuora to Participate in...

Arcturus Therapeutics Holdings Inc. [ARCT] Stock trading around $46.89 per share: What’s Next?

Arcturus Therapeutics Holdings Inc. gained 2.99% or 1.36 points to close at $46.89 with a heavy trading volume of 3736504 shares. It opened...

Renewable Energy Group Inc. [REGI] gain 81.08% so far this year. What now?

Renewable Energy Group Inc. closed the trading session at $48.80 on 09/18/20. The day’s price range saw the stock hit a low of...